Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort

Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial clinical characteristics. In the Danish National Patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric neurology 2020-06, Vol.107, p.57-63
Hauptverfasser: Levison, Lotte Sahin, Thomsen, Reimar Wernich, Markvardsen, Lars Kjøbsted, Christensen, Diana Hedevang, Sindrup, Søren Hein, Andersen, Henning
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 63
container_issue
container_start_page 57
container_title Pediatric neurology
container_volume 107
creator Levison, Lotte Sahin
Thomsen, Reimar Wernich
Markvardsen, Lars Kjøbsted
Christensen, Diana Hedevang
Sindrup, Søren Hein
Andersen, Henning
description Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial clinical characteristics. In the Danish National Patient Registry, we identified all children aged below 16 years (N = 212) diagnosed with Guillain-Barré syndrome and admitted to any Danish department of pediatrics between 1987 and 2016. A total of 145 (68%) medical files could be retrieved and reviewed, enabling classification of patients with true Guillain-Barré syndrome. The nationwide Guillain-Barré syndrome incidence rate was calculated and stratified by age, gender, time periods, and season. Risk factors and initial Guillain-Barré syndrome characteristics were assessed by medical record review. The positive predictive value of Guillain-Barré syndrome diagnosis codes was 86%. The crude Guillain-Barré syndrome incidence rate was 0.69 per 100,000 person years and peaked at two years of age. The incidence rate was higher among men (0.80) than women (0.58) and was relatively stable over the 30-year period. No seasonal difference of the incidence rate was found. Of the 125 Guillain-Barré syndrome cases, 63% were preceded by infection, whereas none were preceded by surgery or malignant disease. Medically treated pain was documented in 70%, mainly confined to the lower extremities. Pediatric Guillain-Barré syndrome diagnoses in the Danish National Patient Registry have high validity, the incidence peaks at age two years, and is preceded by infection in two-thirds of children. Lower extremity pain is a common clinical presentation in the acute setting.
doi_str_mv 10.1016/j.pediatrneurol.2020.01.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2381620421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0887899420300436</els_id><sourcerecordid>2381620421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-beb76c9a2f787333b17de306b7bf5d430fd5a1222fd7c338bb8571104d1ae4013</originalsourceid><addsrcrecordid>eNqNUMtKAzEUDaLYWv0FGXDjZupNMtNkcFWLVqGooC5chUxyB1PaSU1mFD_J7_DHnNIquBMO3M153UPICYUhBTo6mw9XaJ1uQo1t8IshAwZDoB3EDulTKXia0xx2SR-kFKksiqxHDmKcA0BesGyf9DijBZMM-mR8v_FyJpm2brHQrk4vdAhfn8nDR22DX2Li6kQnHNJn1CG51Y3z9buzmEz8iw_NIdmr9CLi0fYOyNPV5ePkOp3dTW8m41lquORNWmIpRqbQrBJdQ85LKixyGJWirHKbcahsriljrLLCcC7LUuaCUsgs1ZgB5QNyuvFdBf_aYmzU0kWDXeUafRsV45KOGGRsTT3fUE3wMQas1Cq4pQ4fioJab6jm6s-Gar2hAtpBdOrjbVBbLtH-an9G6wiXGwJ27745DCoah7XpHAOaRlnv_hX0DaK0igI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2381620421</pqid></control><display><type>article</type><title>Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Levison, Lotte Sahin ; Thomsen, Reimar Wernich ; Markvardsen, Lars Kjøbsted ; Christensen, Diana Hedevang ; Sindrup, Søren Hein ; Andersen, Henning</creator><creatorcontrib>Levison, Lotte Sahin ; Thomsen, Reimar Wernich ; Markvardsen, Lars Kjøbsted ; Christensen, Diana Hedevang ; Sindrup, Søren Hein ; Andersen, Henning</creatorcontrib><description>Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial clinical characteristics. In the Danish National Patient Registry, we identified all children aged below 16 years (N = 212) diagnosed with Guillain-Barré syndrome and admitted to any Danish department of pediatrics between 1987 and 2016. A total of 145 (68%) medical files could be retrieved and reviewed, enabling classification of patients with true Guillain-Barré syndrome. The nationwide Guillain-Barré syndrome incidence rate was calculated and stratified by age, gender, time periods, and season. Risk factors and initial Guillain-Barré syndrome characteristics were assessed by medical record review. The positive predictive value of Guillain-Barré syndrome diagnosis codes was 86%. The crude Guillain-Barré syndrome incidence rate was 0.69 per 100,000 person years and peaked at two years of age. The incidence rate was higher among men (0.80) than women (0.58) and was relatively stable over the 30-year period. No seasonal difference of the incidence rate was found. Of the 125 Guillain-Barré syndrome cases, 63% were preceded by infection, whereas none were preceded by surgery or malignant disease. Medically treated pain was documented in 70%, mainly confined to the lower extremities. Pediatric Guillain-Barré syndrome diagnoses in the Danish National Patient Registry have high validity, the incidence peaks at age two years, and is preceded by infection in two-thirds of children. Lower extremity pain is a common clinical presentation in the acute setting.</description><identifier>ISSN: 0887-8994</identifier><identifier>EISSN: 1873-5150</identifier><identifier>DOI: 10.1016/j.pediatrneurol.2020.01.017</identifier><identifier>PMID: 32192820</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Child ; Child, Preschool ; Cohort Studies ; Female ; GBS characteristics ; GBS epidemiology ; GBS incidence ; GBS risk factors ; GBS validation ; Guillain-Barre Syndrome - diagnosis ; Guillain-Barre Syndrome - epidemiology ; Guillain-Barre Syndrome - etiology ; Guillain-Barre Syndrome - physiopathology ; Humans ; Incidence ; Infant ; Male ; Pediatric GBS ; Registries - statistics &amp; numerical data ; Reproducibility of Results ; Retrospective Studies ; Risk Factors</subject><ispartof>Pediatric neurology, 2020-06, Vol.107, p.57-63</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-beb76c9a2f787333b17de306b7bf5d430fd5a1222fd7c338bb8571104d1ae4013</citedby><cites>FETCH-LOGICAL-c383t-beb76c9a2f787333b17de306b7bf5d430fd5a1222fd7c338bb8571104d1ae4013</cites><orcidid>0000-0002-2210-6020</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pediatrneurol.2020.01.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32192820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Levison, Lotte Sahin</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Markvardsen, Lars Kjøbsted</creatorcontrib><creatorcontrib>Christensen, Diana Hedevang</creatorcontrib><creatorcontrib>Sindrup, Søren Hein</creatorcontrib><creatorcontrib>Andersen, Henning</creatorcontrib><title>Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort</title><title>Pediatric neurology</title><addtitle>Pediatr Neurol</addtitle><description>Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial clinical characteristics. In the Danish National Patient Registry, we identified all children aged below 16 years (N = 212) diagnosed with Guillain-Barré syndrome and admitted to any Danish department of pediatrics between 1987 and 2016. A total of 145 (68%) medical files could be retrieved and reviewed, enabling classification of patients with true Guillain-Barré syndrome. The nationwide Guillain-Barré syndrome incidence rate was calculated and stratified by age, gender, time periods, and season. Risk factors and initial Guillain-Barré syndrome characteristics were assessed by medical record review. The positive predictive value of Guillain-Barré syndrome diagnosis codes was 86%. The crude Guillain-Barré syndrome incidence rate was 0.69 per 100,000 person years and peaked at two years of age. The incidence rate was higher among men (0.80) than women (0.58) and was relatively stable over the 30-year period. No seasonal difference of the incidence rate was found. Of the 125 Guillain-Barré syndrome cases, 63% were preceded by infection, whereas none were preceded by surgery or malignant disease. Medically treated pain was documented in 70%, mainly confined to the lower extremities. Pediatric Guillain-Barré syndrome diagnoses in the Danish National Patient Registry have high validity, the incidence peaks at age two years, and is preceded by infection in two-thirds of children. Lower extremity pain is a common clinical presentation in the acute setting.</description><subject>Adolescent</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>GBS characteristics</subject><subject>GBS epidemiology</subject><subject>GBS incidence</subject><subject>GBS risk factors</subject><subject>GBS validation</subject><subject>Guillain-Barre Syndrome - diagnosis</subject><subject>Guillain-Barre Syndrome - epidemiology</subject><subject>Guillain-Barre Syndrome - etiology</subject><subject>Guillain-Barre Syndrome - physiopathology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Male</subject><subject>Pediatric GBS</subject><subject>Registries - statistics &amp; numerical data</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><issn>0887-8994</issn><issn>1873-5150</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUMtKAzEUDaLYWv0FGXDjZupNMtNkcFWLVqGooC5chUxyB1PaSU1mFD_J7_DHnNIquBMO3M153UPICYUhBTo6mw9XaJ1uQo1t8IshAwZDoB3EDulTKXia0xx2SR-kFKksiqxHDmKcA0BesGyf9DijBZMM-mR8v_FyJpm2brHQrk4vdAhfn8nDR22DX2Li6kQnHNJn1CG51Y3z9buzmEz8iw_NIdmr9CLi0fYOyNPV5ePkOp3dTW8m41lquORNWmIpRqbQrBJdQ85LKixyGJWirHKbcahsriljrLLCcC7LUuaCUsgs1ZgB5QNyuvFdBf_aYmzU0kWDXeUafRsV45KOGGRsTT3fUE3wMQas1Cq4pQ4fioJab6jm6s-Gar2hAtpBdOrjbVBbLtH-an9G6wiXGwJ27745DCoah7XpHAOaRlnv_hX0DaK0igI</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Levison, Lotte Sahin</creator><creator>Thomsen, Reimar Wernich</creator><creator>Markvardsen, Lars Kjøbsted</creator><creator>Christensen, Diana Hedevang</creator><creator>Sindrup, Søren Hein</creator><creator>Andersen, Henning</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2210-6020</orcidid></search><sort><creationdate>202006</creationdate><title>Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort</title><author>Levison, Lotte Sahin ; Thomsen, Reimar Wernich ; Markvardsen, Lars Kjøbsted ; Christensen, Diana Hedevang ; Sindrup, Søren Hein ; Andersen, Henning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-beb76c9a2f787333b17de306b7bf5d430fd5a1222fd7c338bb8571104d1ae4013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>GBS characteristics</topic><topic>GBS epidemiology</topic><topic>GBS incidence</topic><topic>GBS risk factors</topic><topic>GBS validation</topic><topic>Guillain-Barre Syndrome - diagnosis</topic><topic>Guillain-Barre Syndrome - epidemiology</topic><topic>Guillain-Barre Syndrome - etiology</topic><topic>Guillain-Barre Syndrome - physiopathology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Male</topic><topic>Pediatric GBS</topic><topic>Registries - statistics &amp; numerical data</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levison, Lotte Sahin</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Markvardsen, Lars Kjøbsted</creatorcontrib><creatorcontrib>Christensen, Diana Hedevang</creatorcontrib><creatorcontrib>Sindrup, Søren Hein</creatorcontrib><creatorcontrib>Andersen, Henning</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levison, Lotte Sahin</au><au>Thomsen, Reimar Wernich</au><au>Markvardsen, Lars Kjøbsted</au><au>Christensen, Diana Hedevang</au><au>Sindrup, Søren Hein</au><au>Andersen, Henning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort</atitle><jtitle>Pediatric neurology</jtitle><addtitle>Pediatr Neurol</addtitle><date>2020-06</date><risdate>2020</risdate><volume>107</volume><spage>57</spage><epage>63</epage><pages>57-63</pages><issn>0887-8994</issn><eissn>1873-5150</eissn><abstract>Guillain-Barré syndrome is the most common cause of acute flaccid paresis in childhood. Few validated large-scale population-based data are available concerning pediatric Guillain-Barré syndrome, including incidence, risk factors, and initial clinical characteristics. In the Danish National Patient Registry, we identified all children aged below 16 years (N = 212) diagnosed with Guillain-Barré syndrome and admitted to any Danish department of pediatrics between 1987 and 2016. A total of 145 (68%) medical files could be retrieved and reviewed, enabling classification of patients with true Guillain-Barré syndrome. The nationwide Guillain-Barré syndrome incidence rate was calculated and stratified by age, gender, time periods, and season. Risk factors and initial Guillain-Barré syndrome characteristics were assessed by medical record review. The positive predictive value of Guillain-Barré syndrome diagnosis codes was 86%. The crude Guillain-Barré syndrome incidence rate was 0.69 per 100,000 person years and peaked at two years of age. The incidence rate was higher among men (0.80) than women (0.58) and was relatively stable over the 30-year period. No seasonal difference of the incidence rate was found. Of the 125 Guillain-Barré syndrome cases, 63% were preceded by infection, whereas none were preceded by surgery or malignant disease. Medically treated pain was documented in 70%, mainly confined to the lower extremities. Pediatric Guillain-Barré syndrome diagnoses in the Danish National Patient Registry have high validity, the incidence peaks at age two years, and is preceded by infection in two-thirds of children. Lower extremity pain is a common clinical presentation in the acute setting.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32192820</pmid><doi>10.1016/j.pediatrneurol.2020.01.017</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2210-6020</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0887-8994
ispartof Pediatric neurology, 2020-06, Vol.107, p.57-63
issn 0887-8994
1873-5150
language eng
recordid cdi_proquest_miscellaneous_2381620421
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Child
Child, Preschool
Cohort Studies
Female
GBS characteristics
GBS epidemiology
GBS incidence
GBS risk factors
GBS validation
Guillain-Barre Syndrome - diagnosis
Guillain-Barre Syndrome - epidemiology
Guillain-Barre Syndrome - etiology
Guillain-Barre Syndrome - physiopathology
Humans
Incidence
Infant
Male
Pediatric GBS
Registries - statistics & numerical data
Reproducibility of Results
Retrospective Studies
Risk Factors
title Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A54%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pediatric%20Guillain-Barr%C3%A9%20Syndrome%20in%20a%2030-Year%20Nationwide%20Cohort&rft.jtitle=Pediatric%20neurology&rft.au=Levison,%20Lotte%20Sahin&rft.date=2020-06&rft.volume=107&rft.spage=57&rft.epage=63&rft.pages=57-63&rft.issn=0887-8994&rft.eissn=1873-5150&rft_id=info:doi/10.1016/j.pediatrneurol.2020.01.017&rft_dat=%3Cproquest_cross%3E2381620421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2381620421&rft_id=info:pmid/32192820&rft_els_id=S0887899420300436&rfr_iscdi=true